PPIG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.6993999997832E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.25720000035912E-07 |
Normal-vs-Stage2 |
8.041600E-04 |
Normal-vs-Stage3 |
6.754200E-02 |
Normal-vs-Stage4 |
1.031040E-01 |
Stage1-vs-Stage2 |
8.876400E-01 |
Stage1-vs-Stage3 |
9.778000E-02 |
Stage1-vs-Stage4 |
2.379400E-01 |
Stage2-vs-Stage3 |
2.174400E-01 |
Stage2-vs-Stage4 |
2.661000E-01 |
Stage3-vs-Stage4 |
9.527800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.62330000003297E-07 |
Normal-vs-AfricanAmerican |
6.041000E-04 |
Normal-vs-Asian |
5.422000E-02 |
Caucasian-vs-AfricanAmerican |
3.825400E-01 |
Caucasian-vs-Asian |
7.447800E-01 |
AfricanAmerican-vs-Asian |
9.903400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.73940000472939E-08 |
Normal-vs-Female |
1.405370E-01 |
Male-vs-Female |
4.13570000000751E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.042940E-03 |
Normal-vs-Extreme_Weight |
1.37429999602645E-08 |
Normal-vs-Obese |
6.574700E-04 |
Normal-vs-Extreme_Obese |
1.075930E-03 |
Normal_Weight-vs-Extreme_Weight |
9.169800E-02 |
Normal_Weight-vs-Obese |
7.405200E-01 |
Normal_Weight-vs-Extreme_Obese |
6.823800E-01 |
Extreme_Weight-vs-Obese |
1.277610E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.138400E-01 |
Obese-vs-Extreme_Obese |
5.164200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.897400E-01 |
Normal-vs-Age(41-60Yrs) |
1.198100E-04 |
Normal-vs-Age(61-80Yrs) |
1.31909999590007E-08 |
Normal-vs-Age(81-100Yrs) |
1.137520E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.401760E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.566000E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.719600E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.621100E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.112800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.127400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
5.52329999514711E-08 |
Normal-VS-Type2 PRCC |
5.98399999999222E-05 |
Normal-VS-KIRP CIMP |
3.150200E-01 |
Normal-VS-Unclassified PRCC |
7.802300E-03 |
Type1 PRCC-VS-Type2 PRCC |
3.533000E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.439820E-02 |
Type1 PRCC-VS-Unclassified PRCC |
6.597600E-02 |
Type2 PRCC-VS-KIRP CIMP |
1.801880E-03 |
Type2 PRCC-VS-Unclassified PRCC |
4.535600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.038360E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.04430000494816E-08 |
Normal-vs-N1 |
6.943400E-01 |
Normal-vs-N2 |
9.050000E-02 |
N0-vs-N1 |
1.660020E-03 |
N0-vs-N2 |
3.494200E-01 |
N1-vs-N2 |
3.415800E-01 |
|
|